Table 3.

Inhibition of Bacterial Growth (%) by Compounds 1–12 and Commercial Aminoglycosides at 6.3 µM^a

compound	E. coli	E. faecalis	K. pneumoniae	P. mirabilis	MRSA 33591	MRSA A960649	A. baumannii
1	7	11	0	0	7	2	0
2	84	39	0	87	6	3	0
3	53	3	0	14	6	3	0
4	73	ND	0	80	15	2	ND
5	74	11	0	80	15	0	0
6	87	29	0	52	0	12	0
7	71	0	2	23	7	3	0
8	67	46	0	31	0	1	0
9	38	9	0	2	5	0	0
10	62	0	0	4	2	0	0
11	36	12	0	12 ± 5	2	0	0
12	52	28	0	8	0	2	0
AMA	2	27	0	19	0	0	0
NEO	100	39	0	96	0	0	91

compound	C. freundii	E. cloacae	L. monocytogenes	P. aeruginosa	S. epidermidis	S. flexneri	S. marcescens
1	54 ± 11	24	100	10	98	0	0
2	97	100	100	19	97	43	81 ± 11
3	65 ± 9	27	100	9	100	16	0
4	ND	ND	ND	ND	ND	ND	ND
5	97	76	100	16	100	78	93
6	95	52	100	18	100	48 ± 6	0
7	86	28	100	0	100	23 ± 6	0
8	96	54	100	16	100	54 ± 10	67
9	96	33	100	0	100	53 ± 6	8
10	96	27	100	0	100	67	18 ± 6
11	94	18	100	16	100	36 ± 5	63
12	95	38 ± 8	100	4	100	38 ± 7	68 ± 5
AMA	4	0	37	5	0	9	0
NEO	97	100	100	11	95	100	100

^aStandard error (±) is given for replicate assays when the error was >5%.